Personalized approach: Carbiotix ramps up rare disease therapeutics development as latest funding round closes

As the company’s latest fund round closes, the total funds raised to date are €1m over four years

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

15 Aug 2019 --- ZBiotics, a genetic engineering company in the US focused on consumer health, announces today the official launch of the first genetically-engineered probiotic on... Read More

FormattedPicture

FOOD RESEARCH

15 Aug 2019 --- Children with celiac disease predisposition are more likely to have the disease if they consume large amounts of gluten, according to a new study published in JAMA.... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

14 Aug 2019 --- Consuming flavonoid-rich items such as apples and tea, protects against cancer and cardiovascular heart disease (CVD), particularly for smokers and heavy drinkers,... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

14 Aug 2019 --- Trends may be pegged as fleeting but they have the lasting ability to shape the industry and promote innovation. NutritionInsight speaks to industry experts on the... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

13 Aug 2019 --- Whether a child is born by vaginal delivery or Caesarian section has a major influence on shaping the microbiome, proposes new research in the Journal of... Read More

trans